Surgepays is trading at $0.26 (-7.27%) in pre-market; no new company-specific announcement explaining the August 17, 2026 decline was found.

  • Surgepays released Q2 results on August 14, reporting $1.29 million net income, $0.05 EPS, and $16.20 million revenue, up 40.7% year over year.
  • Shares had already risen 14.36% during the August 14 regular session.
  • Broader pre-market indexes were mixed, offering no clear market-wide explanation.